Drug management of fetal tachyarrhythmias: Are we ready for a systematic and evidence-based approach?

Freek Van den Heuvel; Margreet Th. E. Bink-Boelkens; Gideon J. Du Marchie Sarvaas; Rolf M. F. Berger

Drug management of fetal tachyarrhythmias: Are we ready for a systematic and evidence-based approach?

Freek Van den Heuvel^*
, Margreet Th. E. Bink-Boelkens
, Gideon J. Du Marchie Sarvaas
, Rolf M. F. Berger

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

13 Citations (Scopus)

Abstract

Fetal tachyarrhythmias are a life-threatening condition complicating a small proportion of normal pregnancies. Despite major advances in the (intrauterine) pharmacologic treatment of these arrhythmias over the last years major uncertainties remain. Among these are controversies in the choice of agents in relation to arrhvthmia type, and timing and duration of treatment. Currently, no evidence-based approach to the manacement of fetal tachyarrhythmias is available. An international registry is proposed as an important step toward obtaining the necessary data to develop evidence-based management strategies.

Original language	English
Pages (from-to)	S54-S57
Number of pages	4
Journal	Pace-Pacing and Clinical Electrophysiology
Volume	31
Publication status	Published - Feb-2008
Event	2nd International Congress on Arryhthmias from Neonate to Adult - , Netherlands Duration: 1-Oct-2006 → …

Keywords

fetal cardiology
tachyarrhythmias
drug management
SUPRAVENTRICULAR TACHYCARDIA
HYDROPS-FETALIS
ATRIAL-FLUTTER
FLECAINIDE
DIAGNOSIS
SOTALOL
FETUS
AMIODARONE
THERAPY

Handle.net

Persistent link

Cite this

@article{5f19d3f4bf924d15a1c35f4e6d70a23a,

title = "Drug management of fetal tachyarrhythmias: Are we ready for a systematic and evidence-based approach?",

abstract = "Fetal tachyarrhythmias are a life-threatening condition complicating a small proportion of normal pregnancies. Despite major advances in the (intrauterine) pharmacologic treatment of these arrhythmias over the last years major uncertainties remain. Among these are controversies in the choice of agents in relation to arrhvthmia type, and timing and duration of treatment. Currently, no evidence-based approach to the manacement of fetal tachyarrhythmias is available. An international registry is proposed as an important step toward obtaining the necessary data to develop evidence-based management strategies.",

keywords = "fetal cardiology, tachyarrhythmias, drug management, SUPRAVENTRICULAR TACHYCARDIA, HYDROPS-FETALIS, ATRIAL-FLUTTER, FLECAINIDE, DIAGNOSIS, SOTALOL, FETUS, AMIODARONE, THERAPY",

author = "\{Van den Heuvel\}, Freek and Bink-Boelkens, \{Margreet Th. E.\} and Sarvaas, \{Gideon J. Du Marchie\} and Berger, \{Rolf M. F.\}",

year = "2008",

month = feb,

language = "English",

volume = "31",

pages = "S54--S57",

journal = "Pace-Pacing and Clinical Electrophysiology",

issn = "0147-8389",

publisher = "Wiley",

note = "2nd International Congress on Arryhthmias from Neonate to Adult ; Conference date: 01-10-2006",

}

TY - JOUR

T1 - Drug management of fetal tachyarrhythmias

T2 - 2nd International Congress on Arryhthmias from Neonate to Adult

AU - Van den Heuvel, Freek

AU - Bink-Boelkens, Margreet Th. E.

AU - Sarvaas, Gideon J. Du Marchie

AU - Berger, Rolf M. F.

PY - 2008/2

Y1 - 2008/2

N2 - Fetal tachyarrhythmias are a life-threatening condition complicating a small proportion of normal pregnancies. Despite major advances in the (intrauterine) pharmacologic treatment of these arrhythmias over the last years major uncertainties remain. Among these are controversies in the choice of agents in relation to arrhvthmia type, and timing and duration of treatment. Currently, no evidence-based approach to the manacement of fetal tachyarrhythmias is available. An international registry is proposed as an important step toward obtaining the necessary data to develop evidence-based management strategies.

AB - Fetal tachyarrhythmias are a life-threatening condition complicating a small proportion of normal pregnancies. Despite major advances in the (intrauterine) pharmacologic treatment of these arrhythmias over the last years major uncertainties remain. Among these are controversies in the choice of agents in relation to arrhvthmia type, and timing and duration of treatment. Currently, no evidence-based approach to the manacement of fetal tachyarrhythmias is available. An international registry is proposed as an important step toward obtaining the necessary data to develop evidence-based management strategies.

KW - fetal cardiology

KW - tachyarrhythmias

KW - drug management

KW - SUPRAVENTRICULAR TACHYCARDIA

KW - HYDROPS-FETALIS

KW - ATRIAL-FLUTTER

KW - FLECAINIDE

KW - DIAGNOSIS

KW - SOTALOL

KW - FETUS

KW - AMIODARONE

KW - THERAPY

M3 - Article

SN - 0147-8389

VL - 31

SP - S54-S57

JO - Pace-Pacing and Clinical Electrophysiology

JF - Pace-Pacing and Clinical Electrophysiology

Y2 - 1 October 2006

ER -

Drug management of fetal tachyarrhythmias: Are we ready for a systematic and evidence-based approach?

Abstract

Keywords

Handle.net

Fingerprint

Cite this